Business Insider -
27 Apr 2020 04:49

Olivier Douliery / AFP / Getty MiMedx Group, a biopharmaceutical company, received $10 million from the government's Paycheck Protection Program two weeks after paying the government $6.5 million to resolve allegations it had been knowingly overcharging for medical supplies. Last year the company was also sued for exaggerating its revenue to investors. That case was settled and no fault was admitted. Two of its executives were also indicted on accounting fraud charges. Hilary Dixon, a MiMedx spo...
Share this Article
Comment on this Article
Please to comment